Department news

Institute of Biomedical Engineering (BME) news

newfacultysmall

Meet 14 professors joining U of T Engineering

Fourteen new faculty members working at the leading edge of engineering education and research are joining U of T Engineering, slated to begin on or before July 1, 2017. Five of these professors hold appointments in more than one department. Each brings a unique passion for experiential engineering education, and their research addresses some of […]

Professor Naomi Matsuura (MSE, IBBME), an expert in the design of new materials that interact with medical imaging radiation, joined the Faculty in July 2016. (Credit: Kevin Soobrian)

Treating cancer from within: Q & A with Naomi Matsuura

Professor Naomi Matsuura (MSE, IBBME), an expert in the design of new materials that interact with medical imaging radiation, joined the Faculty in July 2016.

kramayfeature

U of T Engineering doctoral students receive Vanier Scholarships worth $150,000

The three awardees are working to advance solar technology, design brain-machine interfaces and improve drinking water quality

University Professor Molly Shoichet (IBBME, ChemE), holds the hyaluronic acid (HA)-based injectable hydrogel developed in her lab that helps transplanted stem cells survive, integrate and repair damaged tissue in the brain and eye. Shoichet has been named the recipient of the 2016 Till & McCulloch Award. (Credit: Roberta Baker).

Molly Shoichet awarded 2016 Till & McCulloch Award

Pioneering stem-cell researcher developed hydrogel platform to deliver stem cells to brain and eyes, restoring vision by 15 per cent

University Professor Peter Zandstra (IBBME) will be receiving the Scale-Up and Manufacturing of Cell-Based Therapies Award from Engineering Conferences International. (Credit: Neil Ta).

Peter Zandstra recognized for contributions to development and commercialization of stem cell-based therapies

IBBME University Professor to receive Scale-Up and Manufacturing of Cell-Based Therapies Award at Engineering Conferences International

SensOR is a company that makes it easier for surgeons to operate at a distance by providing a way to sense the amount of force being applied to their instruments. The team includes (from left to right): Justin Wee (ECE 1T3, IBBME PhD candidate), co-founder and chief technical officer; Leigh Masotti, head of business development; and Robert Brooks (MIE PhD 1T5), co-founder and chief executive officer.  (Photo: Neil Ta)

Three startups to watch from Demo Day at U of T Engineering’s Entrepreneurship Hatchery

Companies include a robotic exoskeleton for children with physical disabilities, an electronic “smart skin” that helps surgeons avoid errors and a meal replacement that promotes cognitive health

A landmark bequest from Erwin Edward Hart (CivE 4T0, centre) created the Percy Edward Hart and Erwin Edward Hart Professorships, awarded to seven U of T Engineering researchers.

Hart Professorships awarded to seven early-career faculty members

Professorships created by a landmark bequest from the estate of alumnus Erwin Edward Hart (CivE 4T0)

University Professor Michael Sefton (IBBME, ChemE), University of Toronto biomedical engineering University Professor Michael Sefton (IBBME, ChemE) has been awarded the Lifetime Achievement Award from the Tissue Engineering & Regenerative Medicine International Society. (Credit: Neil Ta)

Michael Sefton to receive Lifetime Achievement Award from the Tissue Engineering & Regenerative Medicine International Society

The award, issued by the organization’s Americas chapter, recognizes immense contributions to the fields of tissue engineering and regenerative medicine

U of T doctoral researchers Iliya Sigal (right) and Dene Ringuette are part of a team that designed a miniature microscope that could open new doors for epilepsy and seizure monitoring and treatment. (Credit: Luke Ng).

Battery-sized microscope gives new insights into brain activity during seizures

Technique could offer insights into what causes epilepsy, and lead to more effective treatments for more than 15,000 Canadians diagnosed each year